AegirBio AB (AegirBio AB) Days Payable : 0.00 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB Days Payable?

AegirBio AB's average Accounts Payable for the three months ended in Mar. 2024 was $0.00 Mil. AegirBio AB's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.00 Mil.

The historical rank and industry rank for AegirBio AB's Days Payable or its related term are showing as below:

During the past 4 years, AegirBio AB's highest Days Payable was 235.20. The lowest was 79.45. And the median was 157.33.

AEGBF's Days Payable is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 72.55
* Ranked among companies with meaningful Days Payable only.

AegirBio AB's Days Payable declined from Dec. 2022 (18.19) to Mar. 2024 (0.00). It may suggest that AegirBio AB accelerated paying its suppliers.

AegirBio AB Days Payable Historical Data

The historical data trend for AegirBio AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB Days Payable Chart

AegirBio AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Days Payable

242.91

85.81

AegirBio AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Days Payable	Get a 7-Day Free Trial												18.19	3,263.94	-	-	-

Competitive Comparison of AegirBio AB's Days Payable

For the Medical Devices subindustry, AegirBio AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AegirBio AB's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AegirBio AB's Days Payable distribution charts can be found below:

* The bar in red indicates where AegirBio AB's Days Payable falls into.

AegirBio AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

AegirBio AB's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (0.686	+	0.465)	/	2 )	/	2.448	*	365
=	0.5755					/	2.448	*	365
=	85.81

AegirBio AB's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

AegirBio AB Days Payable Related Terms

Thank you for viewing the detailed overview of AegirBio AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

AegirBio AB (AegirBio AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

AEGIR:Sweden 52Q:Germany

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.aegirbio.com

AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines